TP53 and neoplasm: Given the nutrition competition relationships between bacteria and tumor cells, the EcM-GDH strain can effectively diminish the intracellular glycolytic flux and disrupt the mitochondrial hemostasis of tumors both in vitro and in vivo, activating the pro-death autophagy and p53-initiated apoptosis pathways in response to the catalytic nutrient deprivation.